The global market for Malaria Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Malaria Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Malaria Drugs.

The Malaria Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Malaria Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Malaria Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Malaria Drugs Market Report

Report Metric	Details
Report Name	Malaria Drugs Market
CAGR	5%
Segment by Type	Aryl Aminoalcohol Compounds Antifolate Compounds Artemisinin Compounds
Segment by Application	Prevention Treatment Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis, Ajanta Pharma, Kunming Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Malaria Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Malaria Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Malaria Drugs Market report?

Ans: The main players in the Malaria Drugs Market are Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis, Ajanta Pharma, Kunming Pharmaceutical

What are the Application segmentation covered in the Malaria Drugs Market report?

Ans: The Applications covered in the Malaria Drugs Market report are Prevention, Treatment, Other

What are the Type segmentation covered in the Malaria Drugs Market report?

Ans: The Types covered in the Malaria Drugs Market report are Aryl Aminoalcohol Compounds, Antifolate Compounds, Artemisinin Compounds

1 Malaria Drugs Market Overview

1.1 Product Definition

1.2 Malaria Drugs by Type

1.2.1 Global Malaria Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Aryl Aminoalcohol Compounds

1.2.3 Antifolate Compounds

1.2.4 Artemisinin Compounds

1.3 Malaria Drugs by Application

1.3.1 Global Malaria Drugs Market Value by Application (2024 VS 2031)

1.3.2 Prevention

1.3.3 Treatment

1.3.4 Other

1.4 Global Malaria Drugs Market Size Estimates and Forecasts

1.4.1 Global Malaria Drugs Revenue 2020-2031

1.4.2 Global Malaria Drugs Sales 2020-2031

1.4.3 Global Malaria Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Malaria Drugs Market Competition by Manufacturers

2.1 Global Malaria Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Malaria Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Malaria Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Malaria Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Malaria Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Malaria Drugs, Product Type & Application

2.7 Global Key Manufacturers of Malaria Drugs, Date of Enter into This Industry

2.8 Global Malaria Drugs Market Competitive Situation and Trends

2.8.1 Global Malaria Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Malaria Drugs Players Market Share by Revenue

2.8.3 Global Malaria Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Malaria Drugs Market Scenario by Region

3.1 Global Malaria Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Malaria Drugs Sales by Region: 2020-2031

3.2.1 Global Malaria Drugs Sales by Region: 2020-2025

3.2.2 Global Malaria Drugs Sales by Region: 2026-2031

3.3 Global Malaria Drugs Revenue by Region: 2020-2031

3.3.1 Global Malaria Drugs Revenue by Region: 2020-2025

3.3.2 Global Malaria Drugs Revenue by Region: 2026-2031

3.4 North America Malaria Drugs Market Facts & Figures by Country

3.4.1 North America Malaria Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Malaria Drugs Sales by Country (2020-2031)

3.4.3 North America Malaria Drugs Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Malaria Drugs Market Facts & Figures by Country

3.5.1 Europe Malaria Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Malaria Drugs Sales by Country (2020-2031)

3.5.3 Europe Malaria Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Malaria Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Malaria Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Malaria Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific Malaria Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Malaria Drugs Market Facts & Figures by Country

3.7.1 Latin America Malaria Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Malaria Drugs Sales by Country (2020-2031)

3.7.3 Latin America Malaria Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Malaria Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Malaria Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Malaria Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Malaria Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Malaria Drugs Sales by Type (2020-2031)

4.1.1 Global Malaria Drugs Sales by Type (2020-2025)

4.1.2 Global Malaria Drugs Sales by Type (2026-2031)

4.1.3 Global Malaria Drugs Sales Market Share by Type (2020-2031)

4.2 Global Malaria Drugs Revenue by Type (2020-2031)

4.2.1 Global Malaria Drugs Revenue by Type (2020-2025)

4.2.2 Global Malaria Drugs Revenue by Type (2026-2031)

4.2.3 Global Malaria Drugs Revenue Market Share by Type (2020-2031)

4.3 Global Malaria Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Malaria Drugs Sales by Application (2020-2031)

5.1.1 Global Malaria Drugs Sales by Application (2020-2025)

5.1.2 Global Malaria Drugs Sales by Application (2026-2031)

5.1.3 Global Malaria Drugs Sales Market Share by Application (2020-2031)

5.2 Global Malaria Drugs Revenue by Application (2020-2031)

5.2.1 Global Malaria Drugs Revenue by Application (2020-2025)

5.2.2 Global Malaria Drugs Revenue by Application (2026-2031)

5.2.3 Global Malaria Drugs Revenue Market Share by Application (2020-2031)

5.3 Global Malaria Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Cipla

6.1.1 Cipla Company Information

6.1.2 Cipla Description and Business Overview

6.1.3 Cipla Malaria Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Cipla Malaria Drugs Product Portfolio

6.1.5 Cipla Recent Developments/Updates

6.2 Guilin Pharmaceutical

6.2.1 Guilin Pharmaceutical Company Information

6.2.2 Guilin Pharmaceutical Description and Business Overview

6.2.3 Guilin Pharmaceutical Malaria Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Guilin Pharmaceutical Malaria Drugs Product Portfolio

6.2.5 Guilin Pharmaceutical Recent Developments/Updates

6.3 IPCA Laboratories

6.3.1 IPCA Laboratories Company Information

6.3.2 IPCA Laboratories Description and Business Overview

6.3.3 IPCA Laboratories Malaria Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 IPCA Laboratories Malaria Drugs Product Portfolio

6.3.5 IPCA Laboratories Recent Developments/Updates

6.4 GlaxoSmithKline

6.4.1 GlaxoSmithKline Company Information

6.4.2 GlaxoSmithKline Description and Business Overview

6.4.3 GlaxoSmithKline Malaria Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 GlaxoSmithKline Malaria Drugs Product Portfolio

6.4.5 GlaxoSmithKline Recent Developments/Updates

6.5 Mylan Labs

6.5.1 Mylan Labs Company Information

6.5.2 Mylan Labs Description and Business Overview

6.5.3 Mylan Labs Malaria Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Mylan Labs Malaria Drugs Product Portfolio

6.5.5 Mylan Labs Recent Developments/Updates

6.6 Roche

6.6.1 Roche Company Information

6.6.2 Roche Description and Business Overview

6.6.3 Roche Malaria Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Roche Malaria Drugs Product Portfolio

6.6.5 Roche Recent Developments/Updates

6.7 Novartis

6.7.1 Novartis Company Information

6.7.2 Novartis Description and Business Overview

6.7.3 Novartis Malaria Drugs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Novartis Malaria Drugs Product Portfolio

6.7.5 Novartis Recent Developments/Updates

6.8 Sanofi Aventis

6.8.1 Sanofi Aventis Company Information

6.8.2 Sanofi Aventis Description and Business Overview

6.8.3 Sanofi Aventis Malaria Drugs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Sanofi Aventis Malaria Drugs Product Portfolio

6.8.5 Sanofi Aventis Recent Developments/Updates

6.9 Ajanta Pharma

6.9.1 Ajanta Pharma Company Information

6.9.2 Ajanta Pharma Description and Business Overview

6.9.3 Ajanta Pharma Malaria Drugs Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Ajanta Pharma Malaria Drugs Product Portfolio

6.9.5 Ajanta Pharma Recent Developments/Updates

6.10 Kunming Pharmaceutical

6.10.1 Kunming Pharmaceutical Company Information

6.10.2 Kunming Pharmaceutical Description and Business Overview

6.10.3 Kunming Pharmaceutical Malaria Drugs Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Kunming Pharmaceutical Malaria Drugs Product Portfolio

6.10.5 Kunming Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Malaria Drugs Industry Chain Analysis

7.2 Malaria Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Malaria Drugs Production Mode & Process Analysis

7.4 Malaria Drugs Sales and Marketing

7.4.1 Malaria Drugs Sales Channels

7.4.2 Malaria Drugs Distributors

7.5 Malaria Drugs Customer Analysis

8 Malaria Drugs Market Dynamics

8.1 Malaria Drugs Industry Trends

8.2 Malaria Drugs Market Drivers

8.3 Malaria Drugs Market Challenges

8.4 Malaria Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Cipla Ltd

Guilin Pharmaceutical

Kunming Pharmaceutical

List of Tables

Table 1. Global Malaria Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Malaria Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Malaria Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Malaria Drugs Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Malaria Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Malaria Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Malaria Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Malaria Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Malaria Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Malaria Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Malaria Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Malaria Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Malaria Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Malaria Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Malaria Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Malaria Drugs Sales by Region (2020-2025) & (K Units)

Table 18. Global Malaria Drugs Sales Market Share by Region (2020-2025)

Table 19. Global Malaria Drugs Sales by Region (2026-2031) & (K Units)

Table 20. Global Malaria Drugs Sales Market Share by Region (2026-2031)

Table 21. Global Malaria Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Malaria Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global Malaria Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Malaria Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America Malaria Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Malaria Drugs Sales by Country (2020-2025) & (K Units)

Table 27. North America Malaria Drugs Sales by Country (2026-2031) & (K Units)

Table 28. North America Malaria Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Malaria Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Malaria Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Malaria Drugs Sales by Country (2020-2025) & (K Units)

Table 32. Europe Malaria Drugs Sales by Country (2026-2031) & (K Units)

Table 33. Europe Malaria Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Malaria Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Malaria Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Malaria Drugs Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Malaria Drugs Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Malaria Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Malaria Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Malaria Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Malaria Drugs Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Malaria Drugs Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Malaria Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Malaria Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Malaria Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Malaria Drugs Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Malaria Drugs Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Malaria Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Malaria Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Malaria Drugs Sales (K Units) by Type (2020-2025)

Table 51. Global Malaria Drugs Sales (K Units) by Type (2026-2031)

Table 52. Global Malaria Drugs Sales Market Share by Type (2020-2025)

Table 53. Global Malaria Drugs Sales Market Share by Type (2026-2031)

Table 54. Global Malaria Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Malaria Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Malaria Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global Malaria Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global Malaria Drugs Price (USD/Unit) by Type (2020-2025)

Table 59. Global Malaria Drugs Price (USD/Unit) by Type (2026-2031)

Table 60. Global Malaria Drugs Sales (K Units) by Application (2020-2025)

Table 61. Global Malaria Drugs Sales (K Units) by Application (2026-2031)

Table 62. Global Malaria Drugs Sales Market Share by Application (2020-2025)

Table 63. Global Malaria Drugs Sales Market Share by Application (2026-2031)

Table 64. Global Malaria Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Malaria Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Malaria Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global Malaria Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global Malaria Drugs Price (USD/Unit) by Application (2020-2025)

Table 69. Global Malaria Drugs Price (USD/Unit) by Application (2026-2031)

Table 70. Cipla Company Information

Table 71. Cipla Description and Business Overview

Table 72. Cipla Malaria Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Cipla Malaria Drugs Product

Table 74. Cipla Recent Developments/Updates

Table 75. Guilin Pharmaceutical Company Information

Table 76. Guilin Pharmaceutical Description and Business Overview

Table 77. Guilin Pharmaceutical Malaria Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Guilin Pharmaceutical Malaria Drugs Product

Table 79. Guilin Pharmaceutical Recent Developments/Updates

Table 80. IPCA Laboratories Company Information

Table 81. IPCA Laboratories Description and Business Overview

Table 82. IPCA Laboratories Malaria Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. IPCA Laboratories Malaria Drugs Product

Table 84. IPCA Laboratories Recent Developments/Updates

Table 85. GlaxoSmithKline Company Information

Table 86. GlaxoSmithKline Description and Business Overview

Table 87. GlaxoSmithKline Malaria Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. GlaxoSmithKline Malaria Drugs Product

Table 89. GlaxoSmithKline Recent Developments/Updates

Table 90. Mylan Labs Company Information

Table 91. Mylan Labs Description and Business Overview

Table 92. Mylan Labs Malaria Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Mylan Labs Malaria Drugs Product

Table 94. Mylan Labs Recent Developments/Updates

Table 95. Roche Company Information

Table 96. Roche Description and Business Overview

Table 97. Roche Malaria Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Roche Malaria Drugs Product

Table 99. Roche Recent Developments/Updates

Table 100. Novartis Company Information

Table 101. Novartis Description and Business Overview

Table 102. Novartis Malaria Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Novartis Malaria Drugs Product

Table 104. Novartis Recent Developments/Updates

Table 105. Sanofi Aventis Company Information

Table 106. Sanofi Aventis Description and Business Overview

Table 107. Sanofi Aventis Malaria Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Sanofi Aventis Malaria Drugs Product

Table 109. Sanofi Aventis Recent Developments/Updates

Table 110. Ajanta Pharma Company Information

Table 111. Ajanta Pharma Description and Business Overview

Table 112. Ajanta Pharma Malaria Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Ajanta Pharma Malaria Drugs Product

Table 114. Ajanta Pharma Recent Developments/Updates

Table 115. Kunming Pharmaceutical Company Information

Table 116. Kunming Pharmaceutical Description and Business Overview

Table 117. Kunming Pharmaceutical Malaria Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Kunming Pharmaceutical Malaria Drugs Product

Table 119. Kunming Pharmaceutical Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Malaria Drugs Distributors List

Table 123. Malaria Drugs Customers List

Table 124. Malaria Drugs Market Trends

Table 125. Malaria Drugs Market Drivers

Table 126. Malaria Drugs Market Challenges

Table 127. Malaria Drugs Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Malaria Drugs

Figure 2. Global Malaria Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Malaria Drugs Market Share by Type: 2024 & 2031

Figure 4. Aryl Aminoalcohol Compounds Product Picture

Figure 5. Antifolate Compounds Product Picture

Figure 6. Artemisinin Compounds Product Picture

Figure 7. Global Malaria Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Malaria Drugs Market Share by Application: 2024 & 2031

Figure 9. Prevention

Figure 10. Treatment

Figure 11. Other

Figure 12. Global Malaria Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Malaria Drugs Market Size (2020-2031) & (US$ Million)

Figure 14. Global Malaria Drugs Sales (2020-2031) & (K Units)

Figure 15. Global Malaria Drugs Average Price (USD/Unit) & (2020-2031)

Figure 16. Malaria Drugs Report Years Considered

Figure 17. Malaria Drugs Sales Share by Manufacturers in 2024

Figure 18. Global Malaria Drugs Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Malaria Drugs Players: Market Share by Revenue in Malaria Drugs in 2024

Figure 20. Malaria Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Malaria Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Malaria Drugs Sales Market Share by Country (2020-2031)

Figure 23. North America Malaria Drugs Revenue Market Share by Country (2020-2031)

Figure 24. U.S. Malaria Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Malaria Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Malaria Drugs Sales Market Share by Country (2020-2031)

Figure 27. Europe Malaria Drugs Revenue Market Share by Country (2020-2031)

Figure 28. Germany Malaria Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Malaria Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Malaria Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Malaria Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Malaria Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Malaria Drugs Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Malaria Drugs Revenue Market Share by Region (2020-2031)

Figure 35. China Malaria Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Malaria Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Malaria Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Malaria Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Malaria Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Taiwan Malaria Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Malaria Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Malaria Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Malaria Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Philippines Malaria Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Malaria Drugs Sales Market Share by Country (2020-2031)

Figure 46. Latin America Malaria Drugs Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Malaria Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Malaria Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Malaria Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Malaria Drugs Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Malaria Drugs Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Malaria Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Malaria Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. U.A.E Malaria Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Malaria Drugs by Type (2020-2031)

Figure 56. Global Revenue Market Share of Malaria Drugs by Type (2020-2031)

Figure 57. Global Malaria Drugs Price (USD/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Malaria Drugs by Application (2020-2031)

Figure 59. Global Revenue Market Share of Malaria Drugs by Application (2020-2031)

Figure 60. Global Malaria Drugs Price (USD/Unit) by Application (2020-2031)

Figure 61. Malaria Drugs Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions